Valuation and Earnings
This table compares Atlantic International and its competitors gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Atlantic International | $80,000.00 | -$5.63 million | -0.30 |
Atlantic International Competitors | $3.16 billion | $43.38 million | -15.24 |
Atlantic International’s competitors have higher revenue and earnings than Atlantic International. Atlantic International is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares Atlantic International and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Atlantic International | N/A | -298.20% | -42.32% |
Atlantic International Competitors | -0.66% | 15.30% | 4.24% |
Insider and Institutional Ownership
Risk and Volatility
Atlantic International has a beta of 1.76, meaning that its share price is 76% more volatile than the S&P 500. Comparatively, Atlantic International’s competitors have a beta of 1.14, meaning that their average share price is 14% more volatile than the S&P 500.
Summary
Atlantic International competitors beat Atlantic International on 5 of the 9 factors compared.
Atlantic International Company Profile
Atlantic International Corp. engages in the design, development, and manufacture of genetic analysis technologies. Its services include RNA sequencing and DNA sequencing. The company was founded by William C. St. Laurent and Daniel R. Jones in 2013 and is headquartered in Billercia, MA.
Receive News & Ratings for Atlantic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlantic International and related companies with MarketBeat.com's FREE daily email newsletter.